Dutasteride and Finasteride are both used for BPH and off-label androgenetic alopecia, but they differ on onset, duration and tolerability. Here is the practical comparison.
Dutasteride vs Finasteride
| Factor | Dutasteride | Finasteride |
|---|---|---|
| Class | dual 5-alpha reductase inhibitor | Same therapeutic goal, different pharmacokinetics |
| Onset | measurable DHT suppression within 2 weeks | Comparable or slower depending on formulation |
| Duration | 5-week half-life, daily dosing | Differs: the main reason clinicians switch |
| Strengths | 0.5 mg | Separate titration ladder |
| Typical tolerability issue | libido change | Class-typical, usually mild |
| Generic availability | Widely available from GMP manufacturers | Widely available |
Key takeaways
- Choose Dutasteride when the priority is steady, sustained cover.
- Choose Finasteride when tolerability or dosing convenience matters more.
- Both are available as quality generics, so cost is rarely the deciding factor.
- Switching within class does not usually require a washout period.
Which patient suits which
Patients who want on-demand control and a short exposure window generally do better on Dutasteride. Those who prefer fewer decision points, or who did not tolerate the first option, usually move to Finasteride. Both are prescribed for BPH and off-label androgenetic alopecia and both need the same contraindication check: women and children; do not donate blood for 6 months.
Supply-side view
For pharmacies and telehealth platforms, stocking both gives prescribers a switch option without a re-order delay. ShiningRX ships Dutasteride and Finasteride together on one consignment to reduce freight cost per unit.
Dutasteride at a glance
| Attribute | Detail |
|---|---|
| Drug class | dual 5-alpha reductase inhibitor |
| Common brand | Avodart |
| Licensed use | BPH and off-label androgenetic alopecia |
| Available strengths | 0.5 mg |
| Dosage form | soft gelatin capsule |
| Typical onset | measurable DHT suppression within 2 weeks |
| Duration / dosing interval | 5-week half-life, daily dosing |
| Storage | below 30 °C |